Cargando…
Investigation of Rare Non-Coding Variants in Familial Multiple Myeloma
Multiple myeloma (MM) is a plasma cell malignancy whereby a single clone of plasma cells over-propagates in the bone marrow, resulting in the increased production of monoclonal immunoglobulin. While the complex genetic architecture of MM is well characterized, much less is known about germline varia...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9818386/ https://www.ncbi.nlm.nih.gov/pubmed/36611892 http://dx.doi.org/10.3390/cells12010096 |
_version_ | 1784864973137117184 |
---|---|
author | Niazi, Yasmeen Paramasivam, Nagarajan Blocka, Joanna Kumar, Abhishek Huhn, Stefanie Schlesner, Matthias Weinhold, Niels Sijmons, Rolf De Jong, Mirjam Durie, Brian Goldschmidt, Hartmut Hemminki, Kari Försti, Asta |
author_facet | Niazi, Yasmeen Paramasivam, Nagarajan Blocka, Joanna Kumar, Abhishek Huhn, Stefanie Schlesner, Matthias Weinhold, Niels Sijmons, Rolf De Jong, Mirjam Durie, Brian Goldschmidt, Hartmut Hemminki, Kari Försti, Asta |
author_sort | Niazi, Yasmeen |
collection | PubMed |
description | Multiple myeloma (MM) is a plasma cell malignancy whereby a single clone of plasma cells over-propagates in the bone marrow, resulting in the increased production of monoclonal immunoglobulin. While the complex genetic architecture of MM is well characterized, much less is known about germline variants predisposing to MM. Genome-wide sequencing approaches in MM families have started to identify rare high-penetrance coding risk alleles. In addition, genome-wide association studies have discovered several common low-penetrance risk alleles, which are mainly located in the non-coding genome. Here, we further explored the genetic basis in familial MM within the non-coding genome in whole-genome sequencing data. We prioritized and characterized 150 upstream, 5′ untranslated region (UTR) and 3′ UTR variants from 14 MM families, including 20 top-scoring variants. These variants confirmed previously implicated biological pathways in MM development. Most importantly, protein network and pathway enrichment analyses also identified 10 genes involved in mitogen-activated protein kinase (MAPK) signaling pathways, which have previously been established as important MM pathways. |
format | Online Article Text |
id | pubmed-9818386 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-98183862023-01-07 Investigation of Rare Non-Coding Variants in Familial Multiple Myeloma Niazi, Yasmeen Paramasivam, Nagarajan Blocka, Joanna Kumar, Abhishek Huhn, Stefanie Schlesner, Matthias Weinhold, Niels Sijmons, Rolf De Jong, Mirjam Durie, Brian Goldschmidt, Hartmut Hemminki, Kari Försti, Asta Cells Article Multiple myeloma (MM) is a plasma cell malignancy whereby a single clone of plasma cells over-propagates in the bone marrow, resulting in the increased production of monoclonal immunoglobulin. While the complex genetic architecture of MM is well characterized, much less is known about germline variants predisposing to MM. Genome-wide sequencing approaches in MM families have started to identify rare high-penetrance coding risk alleles. In addition, genome-wide association studies have discovered several common low-penetrance risk alleles, which are mainly located in the non-coding genome. Here, we further explored the genetic basis in familial MM within the non-coding genome in whole-genome sequencing data. We prioritized and characterized 150 upstream, 5′ untranslated region (UTR) and 3′ UTR variants from 14 MM families, including 20 top-scoring variants. These variants confirmed previously implicated biological pathways in MM development. Most importantly, protein network and pathway enrichment analyses also identified 10 genes involved in mitogen-activated protein kinase (MAPK) signaling pathways, which have previously been established as important MM pathways. MDPI 2022-12-26 /pmc/articles/PMC9818386/ /pubmed/36611892 http://dx.doi.org/10.3390/cells12010096 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Niazi, Yasmeen Paramasivam, Nagarajan Blocka, Joanna Kumar, Abhishek Huhn, Stefanie Schlesner, Matthias Weinhold, Niels Sijmons, Rolf De Jong, Mirjam Durie, Brian Goldschmidt, Hartmut Hemminki, Kari Försti, Asta Investigation of Rare Non-Coding Variants in Familial Multiple Myeloma |
title | Investigation of Rare Non-Coding Variants in Familial Multiple Myeloma |
title_full | Investigation of Rare Non-Coding Variants in Familial Multiple Myeloma |
title_fullStr | Investigation of Rare Non-Coding Variants in Familial Multiple Myeloma |
title_full_unstemmed | Investigation of Rare Non-Coding Variants in Familial Multiple Myeloma |
title_short | Investigation of Rare Non-Coding Variants in Familial Multiple Myeloma |
title_sort | investigation of rare non-coding variants in familial multiple myeloma |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9818386/ https://www.ncbi.nlm.nih.gov/pubmed/36611892 http://dx.doi.org/10.3390/cells12010096 |
work_keys_str_mv | AT niaziyasmeen investigationofrarenoncodingvariantsinfamilialmultiplemyeloma AT paramasivamnagarajan investigationofrarenoncodingvariantsinfamilialmultiplemyeloma AT blockajoanna investigationofrarenoncodingvariantsinfamilialmultiplemyeloma AT kumarabhishek investigationofrarenoncodingvariantsinfamilialmultiplemyeloma AT huhnstefanie investigationofrarenoncodingvariantsinfamilialmultiplemyeloma AT schlesnermatthias investigationofrarenoncodingvariantsinfamilialmultiplemyeloma AT weinholdniels investigationofrarenoncodingvariantsinfamilialmultiplemyeloma AT sijmonsrolf investigationofrarenoncodingvariantsinfamilialmultiplemyeloma AT dejongmirjam investigationofrarenoncodingvariantsinfamilialmultiplemyeloma AT duriebrian investigationofrarenoncodingvariantsinfamilialmultiplemyeloma AT goldschmidthartmut investigationofrarenoncodingvariantsinfamilialmultiplemyeloma AT hemminkikari investigationofrarenoncodingvariantsinfamilialmultiplemyeloma AT forstiasta investigationofrarenoncodingvariantsinfamilialmultiplemyeloma |